Do You Still Need Therapy If You Do Ketamine Therapy?

Can Ketamine Replace Therapy? The Short Answer

Ketamine therapy and talk therapy work best as complements, not competitors, and for most people ketamine does not replace an ongoing therapeutic relationship. Across most of ketamine's published outcomes data, roughly 3 in 10 people reach remission, meaning their depression symptoms drop to minimal levels by the end of a course. In Mindbloom's published sublingual data that rate is 28.1%, close to the 28.9% reported for in-clinic IV ketamine (Mathai 2024; McInnes 2022).¹⁻² Individual results may vary. Some people who reach remission choose to stop therapy because they no longer feel they need it. Others keep going because they find it valuable to have someone to talk to, whether or not their symptoms have lifted. Reaching remission is a strict bar, and not reaching it does not mean ketamine did not help. Many people improve meaningfully without reaching it, and for them ketamine can change how much they rely on therapy rather than removing the need for it.

What Is Ketamine-Assisted Psychotherapy (KAP)?

Ketamine-assisted psychotherapy, often shortened to KAP, refers to ketamine treatment paired with structured psychological support rather than ketamine given on its own. In practice, that support can include preparation before a dosing session, some form of guidance around the experience itself, and integration work afterward to make sense of what came up.

There is no single, agreed-upon model for what that support should look like. When researchers reviewed 72 studies of ketamine paired with psychotherapy, the approaches varied so widely that the largest single group, 24 of the 72, did not fit any established school of therapy (Veraart 2026).³ Rather than falling into neat types, programs tend to differ along a few practical lines:

• Who provides the support: a licensed therapist, or a trained guide or facilitator.
• When it happens: during the dosing session itself, or in preparation and integration sessions before and after it.
• How structured it is: a set protocol such as cognitive-behavioral therapy, or a more open, experiential process (Simpson 2026).⁴
• Where it takes place: in a clinic, or remotely at home.

Mindbloom sits at a recognizable point on each of these: an at-home program where trained guides support preparation and integration before and after each session, rather than a therapist working with you during dosing in a clinic.

Do You Need a Therapist to Do Ketamine Therapy?

In most cases, no. Whether a therapist is required depends on the treatment model, not on ketamine itself. Clinic-based ketamine-assisted psychotherapy builds a therapist into the dosing session, so in that setting a therapist is part of the treatment by design. At-home programs and most in-clinic IV infusion services do not require you to have a separate, ongoing therapist in order to begin.

At Mindbloom, you do not need to arrive with a therapist or even a formal diagnosis. A clinician evaluates you during an intake consultation and can establish a qualifying diagnosis at that point, so the assessment is part of getting started rather than a prerequisite you have to satisfy first. In some cases a clinician may decide that ongoing therapeutic support outside of Mindbloom is appropriate before moving forward, which is a clinical judgment made person by person.

It helps to be precise about roles. Mindbloom guides support you through preparation and integration, but they are not licensed therapists and do not treat depression, anxiety, or any other diagnosis. That remains the role of your clinician or a licensed mental health provider you may work with outside the program. Ketamine treatment is meant to work alongside that care, not to stand in for a primary care physician or mental health provider you already rely on.

Can Ketamine Replace Therapy for Depression? What Remission Rates Show

For anyone weighing ketamine therapy for depression, the honest starting point is that no study we have found has followed people over time to see who ends up stopping therapy and who does not. For that reason, remission rates are one of the best proxies we have. The clinical definition of remission is a PHQ-9 score below 5, which means minimal or no remaining symptoms of depression. That gives us our clearest window into the subset of people most likely to feel they can step back from therapy afterward. Not everyone does, of course. Some people keep going because they value having someone to talk to.

By that yardstick, ketamine and psychotherapy land in remarkably similar territory.

Individual results may vary.

This is not meant to be a head-to-head. These studies use different instruments (PHQ-9 below 5 for ketamine, HAM-D below 7 for psychotherapy) and different populations, so it is not a like-for-like ranking. What it does illuminate is that ketamine therapy reaches broadly similar remission rates, and that a leading analysis of psychotherapy reports more than half of patients do not respond and only one third reach remission (Cuijpers 2021).⁶ On remission, in other words, these treatments largely converge. For a closer, like-for-like view, you can compare at-home sublingual ketamine with in-clinic IV.

Most People Improve, Even Without Full Remission

Remission is a strict bar, and many people who benefit from ketamine do not clear it. That is not the same as ketamine not helping. The more common measure is response, meaning your depression symptoms drop by at least half. Mindbloom reports 56.4% response on sublingual ketamine (Mathai 2024).¹ On subcutaneous ketamine, 56.6% respond (Parks 2026).⁵ In-clinic IV ketamine reports a comparable 53.6% (McInnes 2022).² Individual results may vary.

So while about 3 in 10 people reach full remission, more than half cut their symptoms at least in half. The space between those two numbers is people who got substantially better without meeting remission's stricter definition.

Here is a concrete way to picture that middle ground. National health surveillance flags depression at a PHQ-9 score of 10 or higher (NCHS 2025).⁷ The average Mindbloom client finishes a course around 7.9 on sublingual ketamine and 7.7 on subcutaneous, below the line that would identify someone as depressed but not as low as remission's cutoff of 5. That is what getting meaningfully better without full remission looks like.

If you are here because therapy has not worked for you, that is common among people who turn to ketamine, and there is more on options for treatment-resistant depression.

Ketamine Therapy vs. Talk Therapy: How Do They Compare?

People often frame ketamine and talk therapy as an either/or choice, but they are different kinds of treatment, and the clearest difference is practical. Talk therapy is usually an ongoing, open-ended commitment, often weekly sessions over months or years. Ketamine therapy is a defined course of sessions over a matter of weeks.

On outcomes, the two are closer than the "versus" framing suggests. Remission rates land in the same range. The main place they differ is response. In Mindbloom's data, about 56% of people respond within four to six weeks (Mathai 2024).¹ Psychotherapy's rate is 41%, measured at about two months (Cuijpers 2021),⁶ on different scales and in different populations. Higher and earlier is not the same as more effective. Individual results may vary.

So it is not really a contest. Neither treatment requires the other, and choosing one does not rule out the other. Some people use ketamine to get unstuck and keep talk therapy going alongside it, and some do only one.

This article is about depression. If your question is about anxiety instead, we cover ketamine therapy versus CBT for anxiety separately.

What Is Ketamine Integration?

Ketamine integration is the work of making sense of what comes up in a session and turning it into changes that last. It draws on the wider practice of psychedelic integration, and it is a core part of how Mindbloom's program works.

For many people, integration is what separates a powerful session from a lasting change. Setting a clear intention shapes what a session brings up, and taking time to reflect afterward is often what helps those shifts hold in everyday life. It is also where a structured approach to getting the most from treatment does its work.

Do You Have to Do Integration?

No. Integration is not required, and ketamine can help without it. Still, many people find they get more from the experience, and more that lasts, when they do it, which is why it is built into the Mindbloom program with support before and after each session. Some also keep seeing a therapist through the process, often not because they need it to hold their progress but because they find it worthwhile on its own. Wanting to talk to someone is different from needing to.

Ways to Support Integration Between Sessions

Integration does not have to be complicated. A few simple habits help most people:

• Write it down, then revisit it. Note what came up while it is fresh, and look back on it now and then to keep it in view.
• Notice the small shifts. Changes in how you think or react can be subtle, and acknowledging them when they happen brings them into focus so you can build on them.
• Act on the openings. When a moment gives you a chance to respond differently, take it, because repetition is what turns a new reaction into a habit.
• Revisit what felt stuck. The weeks after a session can be a good time to try things that were hard before, and seeing that you can approach them differently becomes its own building block.
• Set an intention for the next session. A clear intention gives the experience an anchor and makes it easier to find meaning in it afterward, which is part of preparing well for each session.

What Clinical Guidelines Say About Ketamine and Psychotherapy

Few clinical guidelines directly address whether ketamine should be paired with therapy. The most detailed recent guidance comes from the 2022 U.S. Department of Veterans Affairs and Department of Defense guideline for major depressive disorder.

Two of its recommendations matter here. First, it recommends treating depression with either psychotherapy or medication on its own, chosen by patient preference (McQuaid 2022).⁸ In other words, a national guideline treats therapy and medication as valid standalone options rather than requiring both. Second, for people who have not responded to several medication trials, it lists ketamine or esketamine as an option, a shift from the previous version, which had advised against ketamine outside research settings.

One detail is worth reading carefully. The ketamine recommendation does not mention psychotherapy, while the very next recommendation, for electroconvulsive therapy, explicitly says it can be offered "with or without psychotherapy." So the guideline pairs therapy with one interventional treatment and stays silent on it for ketamine. That silence means the question has not been settled by guideline bodies, not that they concluded therapy is unnecessary alongside ketamine.